Center No. Clinical features Prevalence in patients [%] Prevalence in controls Ref
1 Mental retardation and/or multiple congenital abnormalities (MR/MCA) 9/1576
[0.57%]
- Doornbos et al.16
2 Mental retardation (MR) 1/64
[1.5%]
- Hirschfeldova et al.25
3 Subjects referred for microarray analysis (behaviour/neurological problems or developmental delay) 69/17 000
[0.41%]
- Burnside et al.28
4 Schizophrenia or
bipolar disorder and idiopathic epilepsy
0/315 1/191
[0.5%]
Stewart et al.36
5 Idiopathic general epilepsies (IGE) 12/1234
[1%]
6/3022
[0.2%]
De Kovel et al.29
6 Childhood absence epilepsy (CAE) 3/198 [1.5%] 0/400 Jiang et al.37
7 Amyotrophic lateral sclerosis 15/4434[0.34%] 15/14618[0.1%] Blauw et al.38
8 Spastic paraplegias (SPG) 2/143
[1.4%]
- Present study
Table 3: The prevalence of 15q11.2 microdeletion in different groups of patients.